| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/02/2009 | US20090087870 Hematological assay and kit |
| 04/02/2009 | US20090087868 Neural Proteins as Biomarkers for Nervous System Injury and Other Neural Disorders |
| 04/02/2009 | US20090087864 Procedure for the determination of the activity of the protease which activates factor VII from protein solutions |
| 04/02/2009 | US20090087858 Two-color Real-time/End-point Quantitation of MicroRNAs (miRNAs) |
| 04/02/2009 | US20090087857 Molecular Beacons for DNA-Photography |
| 04/02/2009 | US20090087856 Method for administering anticoagulation therapy |
| 04/02/2009 | US20090087855 Markers of alterations in the y chromosome and uses therefor |
| 04/02/2009 | US20090087854 Methods for genetic analysis |
| 04/02/2009 | US20090087853 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 04/02/2009 | US20090087852 Mammalian selenoprotein differentially expressed in tumor cells |
| 04/02/2009 | US20090087851 Lineage-Restricted Neuronal Precursors |
| 04/02/2009 | US20090087850 Nucleic acid sequencing methods and systems |
| 04/02/2009 | US20090087849 Nucleic acid-based methods and compositions for the detection of ovarian cancer |
| 04/02/2009 | US20090087848 Determining segmental aneusomy in large target arrays using a computer system |
| 04/02/2009 | US20090087847 Determining a nucleic acid sequence imbalance |
| 04/02/2009 | US20090087846 Method for Detecting Large Mutations and Duplications Using Control Amplification Comparisons to Paralogous Genes |
| 04/02/2009 | US20090087845 Genetic Markers Of True Low Birth Weight |
| 04/02/2009 | US20090087844 Using chromosome 3q13.31 marker expression profiles as evaluative tool in diagnosisng cardiovascular disorders |
| 04/02/2009 | US20090087843 Molecular markers |
| 04/02/2009 | US20090087842 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis; detection and quantification of CAST |
| 04/02/2009 | US20090087841 Methods and compositions for determining resistance of hiv-1 to protease inhibitors |
| 04/02/2009 | US20090087840 Combined extension and ligation for nucleic acid assembly |
| 04/02/2009 | US20090087839 Long distance polymerase chain reaction-based assay for detecting chromosomal rearrangements |
| 04/02/2009 | US20090087838 Analyte detection using autocatalytic chain reactions |
| 04/02/2009 | US20090087837 Method Of Detecting Streptococcus Pneumoniae, Primer Set For The Detection And Kit For The Detection |
| 04/02/2009 | US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies |
| 04/02/2009 | US20090087835 Generating highly specific and highly selective molecular beacon probes by using naturally occurring DNA hairpins present in organisms of interest; identifying a hairpin nucleic acid probe that hybridizes over its entire length to a target nucleic acid molecule |
| 04/02/2009 | US20090087834 Method for characterising polynucleotides |
| 04/02/2009 | US20090087833 Adipogenic adenoviruses as a biomarker for disease |
| 04/02/2009 | US20090087832 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
| 04/02/2009 | US20090087831 Methods for evaluating a bacteriophage preparation |
| 04/02/2009 | US20090087830 Systems and methods for harvesting, storing, and implanting hair grafts |
| 04/02/2009 | US20090087829 Production of monatin enantiomers |
| 04/02/2009 | US20090087517 Bacterial growth enhancer |
| 04/02/2009 | US20090087515 Gene encoding acetolactate synthase and use thereof |
| 04/02/2009 | US20090087451 Methods and Compositions for Vaccination |
| 04/02/2009 | US20090087437 Methods and compositions relating to the regulation of apoptosis by muc1 and bh3-containing proapoptotic proteins |
| 04/02/2009 | US20090087436 Compositions and methods for treating diseases |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087417 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087412 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression |
| 04/02/2009 | DE102008036329A1 Protease activity determination in biological samples and liquid test sample, e.g. blood sample and blood serum, involves withdrawing protease from test sample of protease inhibitor by bringing test sample in contact with support material |
| 04/02/2009 | DE102007044919A1 Verfahren zur Bestimmung von sekundärem Therapieversagen A method for the determination of secondary treatment failure |
| 04/02/2009 | DE102007044664A1 Verdrängungsassay zur Detektion von Nukleinsäureoligomer-Hybridisierungsereignissen Displacement assay for the detection of nucleic acid hybridization events |
| 04/02/2009 | DE102005033855B4 Nanopartikel und Verfahren zum Transportieren eines Nanopartikels Nanoparticles and method for transporting a nanoparticle |
| 04/02/2009 | DE102004061289B4 Testkit mit Testzellen und Immunzellen sowie Herstellverfahren hierfür Test kit with test cells and immune cells and manufacturing method thereof |
| 04/02/2009 | CA2704152A1 Methods for genetic analysis |
| 04/02/2009 | CA2701668A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | CA2700978A1 Individualized cancer treatments |
| 04/02/2009 | CA2700975A1 Methods and systems for genomic analysis using ancestral data |
| 04/02/2009 | CA2700946A1 A system, apparatus and method for applying mechanical force to a material |
| 04/02/2009 | CA2700945A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 04/02/2009 | CA2700941A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| 04/02/2009 | CA2700926A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/02/2009 | CA2700710A1 Polynucleotide primers |
| 04/02/2009 | CA2700532A1 Dual oligonucleotide method of nucleic acid detection |
| 04/02/2009 | CA2700371A1 Method for creating perfusable microvessel systems |
| 04/02/2009 | CA2700231A1 Rapid in vivo identification of biologically active nucleases |
| 04/02/2009 | CA2700219A1 Use of clec1b for the determination of cardiovascular and thrombotic risk |
| 04/01/2009 | EP2042869A2 High affinity TCR proteins and methods |
| 04/01/2009 | EP2042865A2 Systems and methods for distinguishing between a control solution and a physiological sample |
| 04/01/2009 | EP2042612A2 A novel nucleotide mixture for improved nucleic acid amplification performance |
| 04/01/2009 | EP2042610A1 Electrochemical system for determining the coagulation time of blood |
| 04/01/2009 | EP2042609A1 Biosensor |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042603A1 Phosphonate metabolizing plants |
| 04/01/2009 | EP2042597A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 04/01/2009 | EP2042511A1 Method for pre-treatment of serum for analysis of sugar chain |
| 04/01/2009 | EP2041569A2 Lung cancer diagnostic assay |
| 04/01/2009 | EP2041338A1 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects |
| 04/01/2009 | EP2041323A1 Virosomes, methods of preparation, and immunogenic compositions |
| 04/01/2009 | EP2041322A1 Sample cartridge for air-sampling device |
| 04/01/2009 | EP2041320A2 Methods and compositions for the diagnosis and treatment of cancer |
| 04/01/2009 | EP2041319A2 Methods and nucleic acids for analyses of cellular proliferative disorders |
| 04/01/2009 | EP2041318A2 Device and method for extraction and analysis of nucleic acids from biological samples |
| 04/01/2009 | EP2041317A2 Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases |
| 04/01/2009 | EP2041316A2 A method of modifying a macromolecule without prior extraction from a sample |
| 04/01/2009 | EP2041315A2 Methods and compositions for obtaining amplifiable nucleic acids from tissues, cells, or viruses exposed to transport media |
| 04/01/2009 | EP2041314A2 Methylation markers for early detection and prognosis of colon cancers |
| 04/01/2009 | EP2041313A2 Methods of determining the prognosis of an adenocarcinoma |
| 04/01/2009 | EP2041312A1 Abcbi genotyping to predict microtubule-stabilizing-agent-induced toxicity |
| 04/01/2009 | EP2041311A2 Dpyd gene variants and use thereof |
| 04/01/2009 | EP2041310A1 Method for isolating viral nucleic acids |
| 04/01/2009 | EP2041309A1 Prognostic method in colorectal cancer |
| 04/01/2009 | EP2041308A2 Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3 marker |
| 04/01/2009 | EP2041307A2 Prediction of breast cancer response to taxane-based chemotherapy |
| 04/01/2009 | EP2041306A1 A screening method for identifying new drugs |
| 04/01/2009 | EP2041305A1 Disposable device for analyzing a liquid sample containing a nucleic acid with a nucleic acid amplification apparatus |
| 04/01/2009 | EP2041304A1 Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication |
| 04/01/2009 | EP2041303A2 Methods for cancer treatment using tak1 inhibitors |
| 04/01/2009 | EP2041302A1 Pcr screening method |
| 04/01/2009 | EP2041301A1 Identification and quantification of a plurality of biological (micro)organisms or their components |
| 04/01/2009 | EP2041300A2 Method of screening antibacterial drug compounds |
| 04/01/2009 | EP2041299A2 Methods and compositions for detecting rare cells from a biological sample |
| 04/01/2009 | EP2041298A1 Solid culture medium for the detection and/or the species discrimination of glycopeptide-resistant enterococci |
| 04/01/2009 | EP2041297A2 Colorimetric method and relative device for bacterial load detection |
| 04/01/2009 | EP2041282A2 Sdf-i binding nucleic acids |
| 04/01/2009 | EP2041279A2 Biomolecular hybrid material and process for preparing same and uses for same |